Full Text of HB2350 103rd General Assembly
HB2350 103RD GENERAL ASSEMBLY |
| | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024 HB2350 Introduced 2/14/2023, by Rep. Kelly M. Cassidy SYNOPSIS AS INTRODUCED: |
| |
Amends the Accident and Health Article of the Illinois Insurance Code. In provisions concerning pap tests and prostate cancer screenings, provides that required coverage includes an annual cervical smear or Pap smear test for all (rather than female) insureds. Provides that required coverage includes an annual prostate cancer screening for insureds (rather than male insureds) upon the recommendation of a physician licensed to practice medicine in all of its branches for specified individuals. Provides that required coverage includes an annual prostate cancer screening for insureds who are age 40 and over with a genetic predisposition to prostate cancer.
|
| |
| | A BILL FOR |
|
| | | HB2350 | | LRB103 26427 BMS 52790 b |
|
| 1 | | AN ACT concerning regulation.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Illinois Insurance Code is amended by | 5 | | changing Section 356u as follows:
| 6 | | (215 ILCS 5/356u)
| 7 | | Sec. 356u. Pap tests and prostate cancer screenings.
| 8 | | (a) A group policy of accident and health insurance that | 9 | | provides coverage
for hospital or medical treatment or | 10 | | services for illness on an
expense-incurred basis and is | 11 | | amended, delivered, issued, or renewed after January 1, 2024 | 12 | | shall provide coverage, without imposing a deductible, | 13 | | coinsurance, copayment, or any other cost-sharing requirement, | 14 | | for all of
the
following:
| 15 | | (1) An annual cervical smear or Pap smear test for all | 16 | | female insureds.
| 17 | | (2) An annual prostate cancer screening for male | 18 | | insureds upon the recommendation of a physician licensed
| 19 | | to practice medicine in all its branches for:
| 20 | | (A) asymptomatic individuals men age 50 and over;
| 21 | | (B) African-American individuals men age 40 and | 22 | | over; and
| 23 | | (C) individuals men age 40 and over with a family |
| | | HB2350 | - 2 - | LRB103 26427 BMS 52790 b |
|
| 1 | | history of or genetic predisposition to prostate | 2 | | cancer.
| 3 | | (3) Surveillance tests for ovarian cancer for female | 4 | | insureds who are at risk for ovarian cancer. | 5 | | (b) This Section shall not apply to agreements, contracts, | 6 | | or policies that
provide coverage for a specified disease or | 7 | | other limited benefit coverage.
| 8 | | (c) This Section does not apply to coverage of prostate | 9 | | cancer screenings to the extent such coverage would disqualify | 10 | | a high-deductible health plan from eligibility for a health | 11 | | savings account pursuant to Section 223 of the Internal | 12 | | Revenue Code. | 13 | | (d) For the purposes of this Section: | 14 | | "At risk for ovarian cancer" means: | 15 | | (1) having a family history (i) with one or more | 16 | | first-degree relatives with ovarian cancer, (ii) of | 17 | | clusters of women relatives with breast cancer, or (iii) | 18 | | of nonpolyposis colorectal cancer; or | 19 | | (2) testing positive for BRCA1 or BRCA2 mutations. | 20 | | "Prostate cancer screening" means medically viable methods | 21 | | for the detection and diagnosis of prostate cancer, including | 22 | | a digital rectal exam and the prostate-specific antigen test | 23 | | and associated laboratory work. "Prostate cancer screening" | 24 | | includes medically necessary subsequent follow-up testing as | 25 | | directed by a health care provider, including, but not limited | 26 | | to: |
| | | HB2350 | - 3 - | LRB103 26427 BMS 52790 b |
|
| 1 | | (1) urinary analysis; | 2 | | (2) serum biomarkers; and | 3 | | (3) medical imaging, including, but not limited to, | 4 | | magnetic resonance imaging. | 5 | | "Surveillance tests for ovarian cancer" means annual | 6 | | screening using (i) CA-125 serum tumor marker testing, (ii) | 7 | | transvaginal ultrasound, (iii) pelvic examination.
| 8 | | (Source: P.A. 102-1073, eff. 1-1-23 .)
|
|